Literature DB >> 28737095

Impact of Body Mass Index on Complications and Survival after Surgery for Esophageal and Gastro-Esophageal-Junction Cancer.

I Kruhlikava1, J Kirkegård1, F V Mortensen1, D W Kjær1.   

Abstract

BACKGROUND AND AIMS: The impact of body mass index on complications and survival in patients undergoing esophagectomy has been extensively studied with conflicting results. In this study, we assess the impact of body mass index on complications and survival following surgery for esophageal and gastro-esophageal-junction cancer in a Danish population.
MATERIAL AND METHODS: We identified 285 consecutive patients, who underwent curative-intended treatment for esophageal and gastro-esophageal-junction cancer in the period 2003-2010. We manually reviewed the electronic medical records of all patients included in the study. Body mass index was calculated as weight in kilograms divided by height in meters squared. We grouped patients according to their body mass index, using the World Health Organization definition, as underweight (body mass index < 18.5 kg/m2), normal weight (body mass index: 18.5-24.9 kg/m2), overweight (body mass index: 25-29.9 kg/m2), and obese (body mass index ⩽ 30 kg/m2).
RESULTS: Median age at surgery was 65 years (range: 27-84 years), of which 207 (72.6%) were males. Patients with the lowest body mass index and the obese patients seemed to have a higher frequency of minor complications. Anastomotic leakage occurred in less than 10% of the patients and was equally distributed across the groups as was the other major complications. There were no differences in the 1-, 2-, or 5-year survival rates between the four body mass index groups after adjustment for possible confounders. Five-year survival rates for the four body mass index groups were 31.8%, 28.7%, 27.9%, and 26.1%, respectively.
CONCLUSION: Body mass index over 30 or under 18.5 does not seem to affect survival rates or the presence of serious postoperative complications following esophagectomy in patients with esophageal and gastro-esophageal-junction cancers not receiving neoadjuvant oncological treatment.

Entities:  

Keywords:  Esophageal cancer; body mass index; esophageal surgery; esophagectomy; obesity; prognosis

Mesh:

Year:  2017        PMID: 28737095     DOI: 10.1177/1457496916683097

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  5 in total

1.  Risk factors for anastomotic leakage after surgical resections for esophageal cancer.

Authors:  Jonas Herzberg; Tim Strate; Salman Yousuf Guraya; Human Honarpisheh
Journal:  Langenbecks Arch Surg       Date:  2021-05-15       Impact factor: 3.445

2.  Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery.

Authors:  Taishi Yamane; Hiroshi Sawayama; Naoya Yoshida; Takeshi Morinaga; Takahiko Akiyama; Kojiro Eto; Kazuto Harada; Katsuhiro Ogawa; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Yuji Miyamoto; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-09-29       Impact factor: 3.402

3.  A machine learning-based predictor for the identification of the recurrence of patients with gastric cancer after operation.

Authors:  Chengmao Zhou; Junhong Hu; Ying Wang; Mu-Huo Ji; Jianhua Tong; Jian-Jun Yang; Hongping Xia
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

Review 4.  Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses.

Authors:  Robert T van Kooten; Daan M Voeten; Ewout W Steyerberg; Henk H Hartgrink; Mark I van Berge Henegouwen; Richard van Hillegersberg; Rob A E M Tollenaar; Michel W J M Wouters
Journal:  Ann Surg Oncol       Date:  2021-09-05       Impact factor: 5.344

5.  Impact of high body mass index on surgical outcomes and long-term survival among patients undergoing esophagectomy: A meta-analysis.

Authors:  Hua Gao; Hai-Ming Feng; Bin Li; Jun-Ping Lin; Jian-Bao Yang; Duo-Jie Zhu; Tao Jing
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.